Abstract
ES09.04 How I Decide 2nd Line Treatment Options for Relapsed/Refractory Metastatic NSCLC
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have